End organ failure
Data regarding end-organ failure are presented in Table 3. Significantly
more renal failure requiring dialysis was observed in the
ECMO+Impella® group (72% vs.
21%, p=0.09). Stroke rates did not show significant differences between
the groups (ECMO 21% vs. ECMO+Impella® 29%, p=0.82). Subsequent limb
ischemia occurred in 6 cases in the ECMO group and 1 in the
ECMO+Impella® group (p=0.92).